Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.752,62
-0,07%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Aptose Biosciences Inc (APS) Aptose Biosciences Inc (APS) Notizie

APS

Aptose Biosciences (APS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:APS
DataOraFonteTitoloSimboloCompagnia
27/04/202017:02PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - APSTSX:APSAptose Biosciences Inc
27/04/202017:00PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - APSTSX:APSAptose Biosciences Inc
27/04/202016:59PR Newswire (Canada)IIROC Trade Resumption - APSTSX:APSAptose Biosciences Inc
27/04/202016:58PR Newswire (Canada)IIROC Trading Halt - APSTSX:APSAptose Biosciences Inc
10/06/201523:00PR Newswire (US)Aptose Biosciences announces results of annual and special meeting of shareholdersTSX:APSAptose Biosciences Inc
02/06/201520:00PR Newswire (US)Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid LeukemiaTSX:APSAptose Biosciences Inc
05/05/201522:15PR Newswire (US)Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015TSX:APSAptose Biosciences Inc
30/04/201514:00PR Newswire (US)Aptose Biosciences To Host First Quarter Ended March 31, 2015 Financial Results Conference Call and WebcastTSX:APSAptose Biosciences Inc
23/03/201513:30PR Newswire (US)Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory BoardTSX:APSAptose Biosciences Inc
23/03/201513:00PR Newswire (US)Aptose Biosciences to Present at the 12th Annual BIO Asia International ConferenceTSX:APSAptose Biosciences Inc
05/03/201514:00PR Newswire (Canada)Aptose Biosciences to Present at the 27th Annual ROTH ConferenceTSX:APSAptose Biosciences Inc
03/03/201522:30PR Newswire (US)Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014TSX:APSAptose Biosciences Inc
26/02/201514:00PR Newswire (US)Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and WebcastTSX:APSAptose Biosciences Inc
25/02/201522:39PR Newswire (US)Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare ConferenceTSX:APSAptose Biosciences Inc
19/02/201514:00PR Newswire (Canada)Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare ConferenceTSX:APSAptose Biosciences Inc
20/01/201523:02PR Newswire (US)Aptose Biosciences Appoints Dr. Bradley Thompson to the Audit CommitteeTSX:APSAptose Biosciences Inc
14/01/201500:45PR Newswire (US)Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Maligna...TSX:APSAptose Biosciences Inc
12/01/201514:00PR Newswire (Canada)Aptose Biosciences to Present at Biotech Showcase™ 2015TSX:APSAptose Biosciences Inc
15/12/201414:00PR Newswire (Canada)Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of DirectorsTSX:APSAptose Biosciences Inc
09/12/201414:00PR Newswire (US)Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual MeetingTSX:APSAptose Biosciences Inc
05/12/201414:00PR Newswire (US)Aptose Biosciences to Present at Oppenheimer & Co. 25th Annual Healthcare ConferenceTSX:APSAptose Biosciences Inc
03/12/201414:00PR Newswire (US)Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meet...TSX:APSAptose Biosciences Inc
17/11/201414:00PR Newswire (US)Aptose Biosciences to Present at The Stifel 2014 Healthcare ConferenceTSX:APSAptose Biosciences Inc
04/11/201422:00PR Newswire (US)Aptose Biosciences reports results for the four months ended September 30, 2014TSX:APSAptose Biosciences Inc
30/10/201412:01PR Newswire (US)Aptose Biosciences To Host Conference Call and Webcast For Four Month Interim Period Ended September 30, 2014TSX:APSAptose Biosciences Inc
21/10/201414:00PR Newswire (US)Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTOTSX:APSAptose Biosciences Inc
03/10/201413:00PR Newswire (US)Aptose Biosciences to Present at the 2014 BIO Investor ForumTSX:APSAptose Biosciences Inc
01/10/201423:16PR Newswire (US)Aptose Biosciences Announces Reverse Stock SplitTSX:APSAptose Biosciences Inc
29/09/201414:30PR Newswire (US)Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...TSX:APSAptose Biosciences Inc
25/09/201415:48PR Newswire (US)Aptose Biosciences to Present at Upcoming Investor ConferencesTSX:APSAptose Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:APS

La tua Cronologia

EU
D894S
D894S
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network